Abstract
Sleep disturbances and nocturnal disabilities are common in Parkinson’s Disease (PD). The PD sleep scale, second version (PDSS-2), has been proposed as a helpful tool for measuring sleep disorders in PD. We aimed to validate the Italian version of the PDSS-2. One hundred and twenty-three consecutive PD outpatients (76 males) were evaluated by means of PDSS-2, Epworth Sleepiness Scale, Hamilton Depression Rating Scale, Parkinson’s Disease Quality of Life Questionnaire (self-administered scales), Unified Parkinson’s Disease Rating (motor section) and Hoehn and Yahr Scales, and Mini Mental State Examination. PDSS-2 internal consistency was satisfactory (Cronbach’s α: 0.77) with significant item to total score correlation and high intra-class correlation coefficient for test–retest reliability (0.943). Total PDSS-2 score was correlated with the scores on all other clinical scales. The factor analysis identified five factors, related to five areas of nocturnal disturbances, similarly as the original PDSS-2. The five factors mainly reflected: (1) nocturnal movement-related problems, (2) quality of sleep, (3) dreaming distress, (4) fragmentation of sleep and (5) insomnia symptoms. The PDSS-2 scale has confirmed its usefulness in evaluating sleep problems in Italian PD patients.
Similar content being viewed by others
References
Oerlemans WGH, de Weerd AW (2002) The prevalence of sleep disorders in patients with Parkinson’s disease: a self-reported, community-based survey. Sleep Med 3:147–149
Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13:895–899
Chaudhuri KR (2003) Nocturnal symptom complex in PD and its management. Neurology 61:S17–S23
Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J (2005) Progressive sleep ‘destructuring’ in Parkinson’s disease. A polysomnographic study in 46 patients. Sleep Med 6:313–318
Duncan GW, Khoo TK, Yarnall AJ et al (2014) Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord 29:195–202
Hoegl B, Arnulf I, Comella C et al (2010) Scales to assess sleep impairment in Parkinson’s Disease: critique and recommendations. Mov Disord 25:2704–2716
Chaudhuri KR, Pal S, DiMarco A et al (2002) The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73:629–635
Trenkwalder C, Kohnen R, Hoegl B et al (2011) Parkinson’s Disease Sleep Scale-Validation of the revised version PDSS-2. Mov Disord 26:644–652
Suzuki K, Miyamoto T, Miyamoto M et al (2015) Evaluation of cutoff scores for the Parkinson’s disease sleep scale-2. Acta Neurol Scand 131:426–430
Horváth K, Aschermann Z, Acs P et al (2014) Test–retest validity of Parkinson’s Disease Sleep Scale 2nd version (PDSS-2). J Parkinsons Dis 4:687–691
Suzuki K, Miyamoto M, Miyamoto T et al (2012) Nocturnal disturbances and restlessness in Parkinson’s disease: using the Japanese version of the Parkinson’s disease sleep scale-2. J Neurol Sci 318:76–81
Swick TJ, Friedman JH, Chaudhuri KR et al (2014) Associations between severity of motor function and nonmotor symptoms in Parkinson’s Disease: a post hoc analysis of the RECOVER study. Eur Neurol 71:140–147
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653
Askenasy JJ (1993) Sleep in Parkinson’s disease. Acta Neurol Scand 87:167–170
Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ (1990) Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 5:280–285
Rye DB, Jankovic J (2002) Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58:341–346
Arnaldi D, Campus C, Ferrara M et al (2012) What predicts cognitive decline in de novo Parkinson’s disease? Neurobiol Aging 33(1127):e1111–e1120
Hughes TA, Ross HF, Musa S et al (2000) A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 54:1596–1602
Levy G, Schupf N, Tang MX et al (2002) Combined effect of age and severity on the risk of dementia in Parkinson’s disease. Ann Neurol 51:722–729
Gagnon JF, Vendette M, Postuma RB et al (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47
Sinforiani E, Pacchetti C, Zangaglia R, Pasotti C, Manni R, Nappi G (2008) REM behavior disorder, hallucinations and cognitive impairment in Parkinson’s disease: a two-year follow up. Mov Disord 23:1441–1445
Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474
Tsuno N, Besset A, Ritchie K (2005) Sleep and depression. J Clin Psychiatry 66:1254–1269
Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease—epidemiology, mechanisms and management. Nat Rev Neurol 8:35–47
Knie B, Mitra MT, Logishetty K, Chaudhuri KR (2011) Excessive daytime sleepiness in patients with Parkinson’s disease. CNS Drugs 25:203–212
Epstein LJ, Kristo D, Strollo PJ Jr et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5:263–276
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Abbruzzese has received speaker honoraria from Abbvie and Lundbeck. Dr. Nobili has received fees from Piramal for lectures and from Eli-Lilly for board participation. The other authors have indicated no financial conflicts of interest.
Rights and permissions
About this article
Cite this article
Arnaldi, D., Cordano, C., De Carli, F. et al. Parkinson’s Disease Sleep Scale 2: application in an Italian population. Neurol Sci 37, 283–288 (2016). https://doi.org/10.1007/s10072-015-2409-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2409-5